AIA Group Ltd lessened its stake in shares of AMETEK, Inc. (NYSE:AME - Free Report) by 29.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 24,371 shares of the technology company's stock after selling 10,019 shares during the period. AIA Group Ltd's holdings in AMETEK were worth $6,037,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in AME. Provenance Wealth Advisors LLC lifted its stake in AMETEK by 3,305.9% during the third quarter. Provenance Wealth Advisors LLC now owns 579 shares of the technology company's stock worth $143,000 after purchasing an additional 562 shares during the period. TrinityBridge Ltd raised its position in AMETEK by 25.2% in the 3rd quarter. TrinityBridge Ltd now owns 14,878 shares of the technology company's stock valued at $3,687,000 after purchasing an additional 2,998 shares during the last quarter. Associated Banc Corp bought a new position in shares of AMETEK in the third quarter valued at about $327,000. Integrity Alliance LLC. acquired a new stake in AMETEK in the 3rd quarter valued at about $202,000. Finally, Factory Mutual Insurance Co. raised its stake in shares of AMETEK by 4.3% in the third quarter. Factory Mutual Insurance Co. now owns 294,000 shares of the technology company's stock worth $72,833,000 after acquiring an additional 12,000 shares during the last quarter. Institutional investors and hedge funds own 87.43% of the company's stock.
Key AMETEK News
Here are the key news stories impacting AMETEK this week:
- Positive Sentiment: AMETEK reported record Q3 results: earnings of $2.21 per share beat estimates of about $2.11, while revenue of $2.22 billion exceeded forecasts and grew 17.3% year over year. Organic sales growth and margin gains also supported the earnings beat. AMETEK Q3 Earnings Beat Estimates on Organic Sales & Margin Gains
- Positive Sentiment: The company raised its 2026 outlook, forecasting EPS of $8.53–$8.57 and targeting mid-teens sales growth. A record backlog and higher free-cash-flow guidance add support to the outlook. AMETEK forecasts 2026 EPS of $8.53–$8.57
- Positive Sentiment: RBC raised its price target to $308 from $291 and maintained an Outperform rating, signaling continued analyst confidence. RBC raises AMETEK price target
- Neutral Sentiment: Analyst views were mixed: Citigroup lifted its target to $270 but kept a Neutral rating, while Mizuho cut its target to $275 from $285 but retained Outperform. Mizuho adjusts AMETEK price target
- Negative Sentiment: AME fell in a session marked by unusually heavy trading, even as results and guidance improved. That disconnect points to a negative near-term market reaction, though the available reports do not establish a specific fundamental trigger. Why AMETEK stock fell after record results and raised guidance
Insider Transactions at AMETEK
In other news, insider David Hermance sold 6,608 shares of the business's stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $254.00, for a total transaction of $1,678,432.00. Following the completion of the transaction, the insider directly owned 42,509 shares in the company, valued at approximately $10,797,286. The trade was a 13.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.54% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on the stock. Citigroup increased their price target on shares of AMETEK from $263.00 to $270.00 and gave the company a "neutral" rating in a research note on Wednesday. TD Cowen reissued a "buy" rating on shares of AMETEK in a research note on Thursday, August 6th. KeyCorp boosted their target price on AMETEK from $260.00 to $295.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 5th. Royal Bank Of Canada upped their price target on AMETEK from $291.00 to $308.00 and gave the company an "outperform" rating in a research note on Wednesday. Finally, Weiss Ratings cut AMETEK from a "buy (b+)" rating to a "buy (b)" rating in a report on Monday. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat.com, AMETEK presently has an average rating of "Moderate Buy" and a consensus price target of $278.06.
Read Our Latest Stock Report on AMETEK
AMETEK Price Performance
AME opened at $237.29 on Thursday. The company has a fifty day moving average price of $243.65 and a two-hundred day moving average price of $234.51. The firm has a market capitalization of $54.39 billion, a PE ratio of 30.02, a P/E/G ratio of 2.35 and a beta of 0.96. AMETEK, Inc. has a 52 week low of $188.47 and a 52 week high of $261.16. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.76 and a current ratio of 1.43.
AMETEK (NYSE:AME - Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The technology company reported $2.21 earnings per share for the quarter, beating analysts' consensus estimates of $2.11 by $0.10. AMETEK had a return on equity of 17.12% and a net margin of 19.91%. The company had revenue of $2.22 billion for the quarter, compared to the consensus estimate of $2.12 billion. During the same quarter in the prior year, the business posted $1.89 EPS. The firm's quarterly revenue was up 17.3% on a year-over-year basis. As a group, analysts anticipate that AMETEK, Inc. will post 8.41 earnings per share for the current year.
About AMETEK
(
Free Report)
AMETEK, Inc is a global manufacturer of industrial technology solutions. The company develops and produces advanced analytical, monitoring, testing, and measurement instruments, as well as engineered electromechanical products used in industrial, aerospace, defense, energy, medical, and other specialized markets.
AMETEK operates through two primary business groups: Electronic Instruments and Electromechanical. Its products include process and power monitoring systems, analytical instruments, automation and control technologies, aerospace and defense equipment, precision motion-control systems, motors, thermal-management solutions, engineered materials, and specialty metal products.
The company traces its roots to 1930 and has expanded through the development and acquisition of specialized technology businesses.
Recommended Stories
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.